Detalles de la búsqueda
1.
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
Acta Oncol
; 63: 248-258, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38698698
2.
Cost analysis comparison between peripherally inserted central catheters and implanted chest ports in patients with cancer-A health economic evaluation of the PICCPORT trial.
Acta Anaesthesiol Scand
; 64(3): 385-393, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31721153
3.
Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
Br J Anaesth
; 122(6): 734-741, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31005243
4.
Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer.
Acta Oncol
; 56(5): 653-660, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28303751
5.
SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment-a randomized controlled multicenter trial.
Trials
; 23(1): 831, 2022 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180944
6.
[Liver transplantation optional treatment of liver metastases from colorectal cancer]. / Transplantation möjlighet vid kolorektala levermetastaser.
Lakartidningen
; 1172020 04 20.
Artículo
en Sueco
| MEDLINE | ID: mdl-32314327
7.
Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer.
PLoS One
; 13(12): e0209838, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592740
Resultados
1 -
7
de 7
1
Próxima >
>>